FIELD: biotechnology.
SUBSTANCE: invention relates to a method of obtaining a population of dopaminergic neurons from the substantia nigra of mice. This method involves obtaining substantia nigra tissue from mice, incubating the resulting tissue with the GBR-BP dye, dissociating the stained tissue to obtain a cell suspension with partially dissociated tissue, incubating the resulting cell suspension with partially dissociated tissue together with DRAQ5 and GBR-BP dyes, repeated dissociation stained cell suspension with partially dissociated tissue to obtain a stained cell suspension and isolating DRAQ5+/GBR-BP+ cells from the resulting stained cell suspension.
EFFECT: invention is used to increase the efficiency of obtaining a population of dopaminergic neurons.
4 cl, 8 dwg, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC DRUG FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND ITS USE | 2019 |
|
RU2799454C2 |
| PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
| RECOVERED MYELOID-LIKE CELL POPULATIONS AND METHOD OF TREATING WITH USING SUCH POPULATIONS | 2007 |
|
RU2473686C2 |
| METHOD OF OBTAINING POPULATION OF NEURAL DIFFERENTIATION INDUCED STROMAL CELLS OF FAT TISSUE | 2008 |
|
RU2396345C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DEGENERATIVE NEUROLOGICAL DISORDERS WHICH COMPRISES, AS AN ACTIVE INGREDIENT, A MIXED ROOT EXTRACT OF THE TREE PEONY ROOT, THE ROOT OF DAHURIC ANGELICA AND THE ROOT OF THOROWAX OR ITS FRACTION | 2015 |
|
RU2668135C1 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURONS OR NEURODEGENERATION | 2011 |
|
RU2722018C2 |
| TRANSPLANTATION OF NERVE CELLS FOR TREATMENT OF NEURODEGENERATIVE STATES | 2005 |
|
RU2434636C2 |
| PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE | 2012 |
|
RU2618412C2 |
| GENETIC NUCLEOTIDE SEQUENCES OF ARTIFICIALLY MODIFIED GDNF WITH DELETED pro-REGION, PRODUCT OF WHICH HAS IMPROVED PROPERTIES NEURAL INDUCTOR AND STIMULATOR OF FORMATION OF NEURAL PROCESSES, SUITABLE FOR THERAPY OF NEURAL INJURIES, ISCHEMIC STROKES AND NEURODEGENERATIVE DISEASES, EXPRESSION VECTOR, MODIFIED WITH GDNF | 2014 |
|
RU2595377C2 |
